Table 1 Patients characteristics at commencement of antiretroviral therapy in the HIV Centre Belgrade (HCB) and Royal Free Hospital (RFH) London
HCB | RFH | P-value | ||
|---|---|---|---|---|
Number | 597 (100 %) | 1763 (100 %) | ||
Gender | Male | 478 (80 %) | 1234 (70 %) | <0.0001 |
Female | 119 (20 %) | 529 (30 %) | ||
Age | Median (IQR) | 38 (32-44) | 36 (32-43) | 0.05 |
Ethnicity | White | 597 (100 %) | 892 (51 %) | <0.0001 |
Black African | 0 (0 %) | 530 (30 %) | ||
Other | 0 (0 %) | 341 (19 %) | ||
Risk for HIV Acquisition | Sex between men | 218 (37 %) | 850 (48 %) | <0.0001 |
Heterosexual | 155 (26 %) | 839 (48 %) | ||
Injecting Drug Use | 90 (15 %) | 49 (3 %) | ||
Other | 134 (22 %) | 25 (1 %) | ||
Calendar year | 2003-2005 | 268 (45 %) | 682 (39 %) | |
2006-2008 | 126 (21 %) | 648 (37 %) | ||
2009-2012 | 203 (34 %) | 433 (25 %) | ||
Previous AIDS | Yes | 361 (61 %) | 337 (19 %) | <0.0001 |
CD4+ T-cells count (cells/mm3) | Median (IQR) | 177 (85, 298) | 238 (123, 339) | <0.0001 |
(N = 575)* | (N = 1519)** | |||
pVL (log10 copies/mL) | Median (IQR) | -+ | 4.9 (4.3, 5.4) (N = 1466)*** | - |
Previous TB diagnosis | Yes | 28 (5 %) | 127 (7 %) | 0.03 |
HCV Ab status | Positive | 131 (22 %) | 88 (5 %) | <0.0001 |
Negative | 466 (78 %) | 1005 (57 %) | ||
Unknown | 0 (0 %) | 688 (39 %) | ||
HBV sAg status | Positive | 78 (13 %) | 53 (3 %) | <0.0001 |
Negative | 56 (87 %) | 1005 (57 %) | ||
Unknown | 0 (0 %) | 705 (40 %) |